Table 1.
Age-associated changes | Plausible Mechanisms | Possible relation to human disease |
---|---|---|
Cardiovascular structural remodeling | ||
↑Vascular intimal thickness | ↑Migration of and ↑matrix production by VSMC Possible derivation of intimal cells from other sources | Early stages of atherosclerosis |
↑Vascular stiffness | Elastin fragmentation ↑Elastase activity ↑Collagen production by VSMC and ↑ Cross linking of collagen Altered growth factor regulation/tissue repair mechanisms |
Systolic Hypertension LV wall thickening Stroke Atherosclerosis |
↑LV wall thickness | ↑LV myocyte size with altered Ca2+ handling ↓Myocyte number (necrotic and apoptotic death) Altered growth factor regulation Focal matrix collagen deposition |
Retarded early diastolic cardiac filling ↑Cardiac filling pressure Lower threshold for dyspnea ↑Likelihood of heart failure with relatively normal systolic function |
↑Left atrial size | ↑Left atrial pressure/volume | ↑Prevalence of lone atrial fibrillation and other atrial arrhythmias |
Cardiovascular functional changes | ||
Altered regulation of vascular tone | ↓NO production/effects | Vascular stiffening; hypertension Early atherosclerosis |
Reduced threshold for cell Ca2+ overload | Changes in gene expression of proteins that regulate Ca2+ handling; increased ω6ω3 PUFA ratio in cardiac membranes | Lower threshold for atrial and ventricular arrhythmia Increased myocyte death Increased fibrosis |
↑Cardiovascular reserve | Lower threshold for, and increased severity of heart failure | |
Reduced physical activity | Learned lifestyle | Exaggerate age changes in some aspects of CV structure and function. Negative impact on atherosclerotic vascular disease, hypertension, and heart failure |
Abbreviations: LV, Left ventricular; PUFA, polyunsaturated fatty acids;